Until now innovation in Pharma Services has been evolutionary. As we come back from COVID, the industry will need to rapidly adopt solutions to respond to travel and study visit disruption, and new patient enrollment, retention, and adherence challenges. We’re helping clients develop and execute strategies to navigate spikes in demand as well as resolve capabilities gaps.
